U.S. trial test machine that ‘reconditions’ lungs outside body

(Reuters) – A machine that ‘reconditions’ a donor’s lungs outside the body before being transplanted into a recipient is undergoing tests in the United States in the hope that it can radically improve survival rates for people with chronic respiratory diseases. The XPS, manufactured by Swedish company XVIVO Perfusion , is in clinical trials at 16 U.S. medical centers. Known as “the box,” it ventilates the lungs after removal from the donor and infuses them with a fluid mix of drugs and steroids, effectively drying them out and getting them in better shape for use in a transplant operation. The technology, which has not been used widely before, aims to increase the donor pool by reconditioning marginal lungs not suitable for transplant. “It allows the lungs to stay alive … and allows us as providers to assess the function of the organ in a unique, well-controlled environment,” said Dr. Varun Puri, an associate professor of cardiothoracic surgery at Washington University in St. Louis. The XPS, which is under test at Washington University, Duke University Medical Center, New York-Presbyterian Hospital and more than a dozen other U.S. sites, has been cleared for use in Europe and Canada and was approved for clinical trials by the U.S. Food and Drug Administration as a Humanitarian Use Device. Michele Coleman, 63, credits ‘the box’ with saving her life. A former smoker, she was diagnosed with chronic obstructive pu...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Respiratory XVIVO Perfusion Source Type: news

Related Links:

Condition:   COPD Intervention:   Drug: BDP/FF/G fixed combination Sponsor:   Chiesi Farmaceutici S.p.A. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 22 May 2019Source: Journal of Environmental SciencesAuthor(s): Rui Chi, Hongyu Li, Qian Wang, Qiangrong Zhai, Daidai Wang, Meng Wu, Qichen Liu, Shaowei Wu, Qingbian Ma, Furong Deng, Xinbiao GuoPrevious studies have reported associations of short-term exposure to different sources of ambient fine particulate matter (PM2.5) and increased mortality or hospitalizations for respiratory diseases. Few studies, however, have focused on the short-term effects of source-specific PM2.5 on emergency room visits (ERVs) of respiratory diseases. Source apportionment for PM2.5 was performed with Positive...
Source: Journal of Environmental Sciences - Category: Environmental Health Source Type: research
DALLAS--Results of 3 studies presented at the American Thoracic Society meeting this week focus on the predictive role of disease exacerbations, machine learning, and Hgb levels in COPD.  
Source: ConsultantLive - Category: Internal Medicine Authors: Tags: Conferences/ATS COPD Respiratory Diseases Source Type: news
Individuals with HDHP more likely to report forgoing care due to costs, cost - related nonadherence
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Emergency Medicine, Nursing, Pulmonology, Conference News, Source Type: news
THURSDAY, May 23, 2019 -- As a rule, high-deductible health plans carry lower premiums than low-deductible plans. But that might not be such a great deal for patients struggling with chronic obstructive pulmonary disease (COPD), new research...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
THURSDAY, May 23, 2019 -- For patients with chronic obstructive pulmonary disease (COPD), high-deductible health plans (HDHPs) are associated with increased likelihood of reporting foregoing care because of costs and cost-related nonadherence,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Title: COPD May Strike Women Harder Than MenCategory: Health NewsCreated: 5/22/2019 12:00:00 AMLast Editorial Review: 5/23/2019 12:00:00 AM
Source: MedicineNet Lungs General - Category: Respiratory Medicine Source Type: news
(Pulmonx) Piedmont Atlanta Hospital is the first in the state of Georgia to offer a new minimally invasive treatment for emphysema, a severe form of Chronic Obstructive Pulmonary Disease (COPD).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
The mechanisms underlying airflow obstruction in COPD cannot be distinguished by standard spirometry. We ascertain whether mathematical modeling of airway biomechanical properties, as assessed from spirometry,...
Source: Respiratory Research - Category: Respiratory Medicine Authors: Tags: Research Source Type: research
Conclusion: 16 of 19 studies treated by CHM granules only showed positive result in 7 diseases and negative result in 1 disease. 17 of 21 studies treated by combination therapy against conventional therapy showed positive result in 6 diseases and negative result in 3 diseases. However, both the absolute and relative effectiveness of CHM formula granules compared with placebo need to be considered clinically. PMID: 31110552 [PubMed]
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
More News: Cardiology | Chronic Obstructive Pulmonary | Clinical Trials | Environmental Health | Food and Drug Administration (FDA) | Heart | Hospitals | Lung Transplant | Medical Devices | Perfusion | Respiratory Medicine | Smokers | Statistics | Transplant Surgery | Transplants | Washington University